NCT01594242 2019-04-16
Autophagy Induction After Bortezomib for Myeloma
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Completed
Clinical Trials
3 trialsNCT01171092 2017-01-11
A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma
University of Kansas Medical Center
Phase EARLY_PHASE1 Completed
NCT00437086 2014-10-17
Bortezomib in Treating Patients With Advanced Myeloproliferative Disorders
Mayo Clinic
Phase EARLY_PHASE1 Completed